Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Further Reading

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

4 Apr 2011
Techne's R&D Systems acquires Boston Biochem assets

Techne's R&D Systems acquires Boston Biochem assets

4 Apr 2011
Researchers develop new way to stimulate neuron production in adult brain

Researchers develop new way to stimulate neuron production in adult brain

4 Apr 2011
Scientists identify five new genes that increase risk of developing Alzheimer's

Scientists identify five new genes that increase risk of developing Alzheimer's

4 Apr 2011
Researchers identify four new genes linked to Alzheimer's disease

Researchers identify four new genes linked to Alzheimer's disease

4 Apr 2011
Common genetic variation linked to bladder cancer risk and telomere length

Common genetic variation linked to bladder cancer risk and telomere length

4 Apr 2011
Discovery of 4 new genes associated with Alzheimer's

Discovery of 4 new genes associated with Alzheimer's

3 Apr 2011
Stem Cell Action Coalition issues urgent appeal to Minnesota Governor for SCNT research

Stem Cell Action Coalition issues urgent appeal to Minnesota Governor for SCNT research

2 Apr 2011
Brain Canada issues statement reinforcing need for government support for brain research funding

Brain Canada issues statement reinforcing need for government support for brain research funding

2 Apr 2011
New Acti-Kare Responsive In-Home Care branch established in Ohio

New Acti-Kare Responsive In-Home Care branch established in Ohio

2 Apr 2011
Researchers study role of acetylation in Alzheimer's disease

Researchers study role of acetylation in Alzheimer's disease

1 Apr 2011
Insulin could play a new role in fighting Alzheimer's disease: Research

Insulin could play a new role in fighting Alzheimer's disease: Research

1 Apr 2011
AAN honors Mayo Clinic researcher with John Dystel Prize for MS work

AAN honors Mayo Clinic researcher with John Dystel Prize for MS work

1 Apr 2011
Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

31 Mar 2011
Adeona reports $3,164,512 net revenue for 2010

Adeona reports $3,164,512 net revenue for 2010

31 Mar 2011
Basic Yellow 1 dye extends lifespan in healthy nematodes, slows Alzheimer's disease-like pathology in worms

Basic Yellow 1 dye extends lifespan in healthy nematodes, slows Alzheimer's disease-like pathology in worms

31 Mar 2011
Thirty four new beneficial compounds found in pure maple syrup

Thirty four new beneficial compounds found in pure maple syrup

31 Mar 2011
IAN launches major survey to study elopement, wandering behavior in individuals with ASD

IAN launches major survey to study elopement, wandering behavior in individuals with ASD

31 Mar 2011
Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

31 Mar 2011
ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

30 Mar 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback